Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$25,078,577
+$2,444,877 QoQ
Shares Held
1,368,918
-2.1% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#38
of 257 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ERAS ranks #29 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ERAS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,078,577 | 1,368,918 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,633,700 | 1,398,869 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,162,372 | 850,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,212,710 | 1,015,005 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $942,975 | 742,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,310,414 | 956,507 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,843,830 | 1,133,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,524,430 | 1,291,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,717,236 | 1,575,100 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,361,096 | 1,631,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,278,105 | 2,008,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,461,937 | 742,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,178,692 | 1,151,700 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,387,646 | 1,457,690 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,528,218 | 354,575 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $766,989 | 137,700 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $182,320 | 21,200 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||